Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
LetterLetter

An Explanation for Putaminal CT, MR, and Diffusion Abnormalities Secondary to Nonketotic Hyperglycemia

Din-E Shan
American Journal of Neuroradiology January 2005, 26 (1) 194-195;
Din-E Shan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

Wintermark et al (1) recently reported findings of high signal intensity on T1-weighted MR images and faint hyperattenuation of involved putamen on CT scans one month later. In addition, the putamen appeared hyperintense on the exponential diffusion-weighted (DW) images. The authors tried to propose an explanation by assuming that protein desiccation occurring in the course of Wallerian degeneration could explain the CT hyperattenuation and the MR imaging and DW imaging patterns in the early phase. I think this explanation is inadequate.

First, I had previously reported 10 cases of hemichorea-hemiballism with similar CT and MR imaging findings and collected 13 more cases to date (2). A key finding in my article was that there was a mismatch between the size of lesions detected on CT scans and on T1-weighted MR images, and also a mismatch between their evolutions over time. It appeared that the lesions on CT and on T1-weighted MR images resulted from two different pathophysiological mechanisms running in parallel. It is not appropriate to make an attempt to give one explanation for two pathologic processes, although they may be triggered by the same event.

Second, it is now clear that the high signal intensity lesions on T1-weighted MR images are related to manganese accumulation in the reactive astrocytes after ischemia. In their article published in 1999, Fujioka et al (3) reproduced the MR imaging finding in rats 7 days after 15-minute occlusion of the middle cerebral artery but not after 60-minute occlusion. Histologic examination revealed that this specific ischemic change disclosed by MR imaging corresponded to selective neuronal death and gliosis, with preservation of the macroscopic structure of the brain, a finding similar to what I reported after histologic analysis of a biopsy specimen obtained from my patient. We both agreed that the MR imaging finding resulted from a progressive pathologic reaction in an incomplete infarction, which confirmed my hypothesis proposed in the 1998 article; that is, the MR imaging finding was related more to vascular compromise than to petechial hemorrhage or hyperglycemia (4). In their latest paper, Fujioka et al demonstrated a similar time course of the appearance of high signal intensity on T1-weighted MR images and the accumulation of tissue manganese accompanied by Mn-superoxide dismutase and glutamine synthetase induction in reactive astrocytes (3).

Third, the restricted diffusion on the DW images reported by Wintermark et al provided additional evidence that ischemia did occur early in the disease course. It is not required to discard such a good explanation for the purpose of keeping one explanation for both findings.

Fourth, while the mechanism responsible for the hyperattenuation on CT scans remains inconclusive, protein desiccation during Wallerian degeneration appears not to be the best explanation. Protein breakdown usually occurs from 4 to 14 weeks after injury, whereas the hyperintense lesions on CT scans in many of these patients occur early in the disease course. To the best of my knowledge, manganese deposition in the brain is not associated with hyperattenuation on CT scans. Microbleeds or “reversible calcium deposition or influx” remains a possible explanation.

References

  1. ↵
    Wintermark M, Fischbein NJ, Mukherjee P, Yuh EL, Dillon WP. Unilateral putaminal CT, MR, and diffusion abnormalities secondary to nonketotic hyperglycemia in the setting of acute neurologic symptoms mimicking stroke. AJNR Am J Neuroradiol 2004;25:975–976
    Abstract/FREE Full Text
  2. ↵
    Shan DE, Ho DM, Chang C, Pan HC, Teng MM. Hemichorea-hemiballism: an explanation for MR signal changes. AJNR Am J Neuroradiol 1998;19:863–870
    Abstract
  3. ↵
    Fujioka M, Taoka T, Matsuo Y, et al. Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration. Ann Neurol 2003;54:732–747
    CrossRefPubMed
  4. ↵
    Shan DE. Delayed ischemic hyperintensity of T1-weighted MRI. Stroke 2000;31:797–798

Reply

We appreciate Dr. Shan for his interesting comments regarding our hypothesis that the observed CT and MR imaging findings in a patient with nonketotic hyperglycemia resulted from an initial hyperglycemic and/or hyperosmolar putaminal insult inducing in turn some degree of Wallerian degeneration of the internal white matter of the putamen.

Dr. Shan states that an attempt to give a single explanation for different pathologic processes is inadequate and raises several points that we would like to address. Relying on a recent reference (1), he suggests that the observed T1 hyperintensity results from manganese accumulation following incomplete brain infarction. He also suggests that the observed restriction of diffusion is a direct consequence of brain ischemia. Finally, Dr. Shan explains the CT hyperattenuation by microbleeds or a “reversible calcium deposit or influx.”

Let us examine these possibilities one by one.

Dr. Shan’s explanation of the CT hyperattenuation by microbleeds or a “reversible calcium deposit or influx” is contradicted by the absence of susceptibility effect on gradient-echo images, as observed in our patient and also as reported in previous articles (2). Furthermore, blood or calcification does not account for restricted diffusion.

Regarding the DW image abnormality, the persistence of restricted diffusion reported in nonketotic hyperglycemia, is different from that typically observed in cases of brain ischemia and suggests a different pathophysiological mechanism (2).

Finally, the accumulation of manganese, which results from an increase in the activity of an enzyme called manganese superoxide-dismutase, is not specific to brain ischemia (1) and can be triggered by multiple stimuli, including hyperglycemia (3, 4), as in the case of our patient.

Hence, the alternative explanation suggested by Dr. Shan for the imaging findings in the case of nonketotic hyperglycemia is not entirely convincing. Our hypothesis of an initial hyperglycemic and/or hyperosmolar putaminal insult, followed by some degree of Wallerian degeneration, has the advantage of proposing one single scientific explanation for the different CT and MR imaging findings. We agree that this has to be evaluated in a study involving longitudinal patient follow-up, which unfortunately could not be obtained in our patient. Considering our hypothesis, diffusion tensor imaging might represent a key tool for better understanding the constellation of brain imaging abnormalities in nonketotic hyperglycemia.

References

  1. ↵
    Fujioka M, Taoka T, Matsuo Y, et al. Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration. Ann Neurol 2003;54:732–747
  2. ↵
    Chu K, Kang DW, Kim DE, Park SH, Roh JK. Diffusion-weighted and gradient echo magnetic resonance findings of hemichorea-hemiballismus associated with diabetic hyperglycemia: a hyperviscosity syndrome? Arch Neurol 2002;59:448–452
    CrossRefPubMed
  3. ↵
    Singh P, Jain A, Kaur G. Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem 2004;260:153–159
    CrossRefPubMed
  4. ↵
    Kimura F, Hasegawa G, Obayashi H, et al. Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. Diabetes Care 2003;26:1246–1250
    Abstract/FREE Full Text
  • Copyright © American Society of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 26 (1)
American Journal of Neuroradiology
Vol. 26, Issue 1
1 Jan 2005
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An Explanation for Putaminal CT, MR, and Diffusion Abnormalities Secondary to Nonketotic Hyperglycemia
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
An Explanation for Putaminal CT, MR, and Diffusion Abnormalities Secondary to Nonketotic Hyperglycemia
Din-E Shan
American Journal of Neuroradiology Jan 2005, 26 (1) 194-195;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An Explanation for Putaminal CT, MR, and Diffusion Abnormalities Secondary to Nonketotic Hyperglycemia
Din-E Shan
American Journal of Neuroradiology Jan 2005, 26 (1) 194-195;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Fair Performance of CT in Diagnosing Unilateral Vocal Fold Paralysis
  • Reply:
  • Regarding “Altered Blood Flow in the Ophthalmic and Internal Carotid Arteries in Patients with Age-Related Macular Degeneration Measured Using Noncontrast MR Angiography at 7T”
Show more LETTERS

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire